OCUL

Ocular Therapeutix, Inc. - Common Stock (OCUL)

About Ocular Therapeutix, Inc. - Common Stock (OCUL)

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Details

Daily high

$8.59

Daily low

$8.17

Price at open

$8.30

52 Week High

$11.78

52 Week Low

$5.78

Market cap

1.3B

Dividend yield

0.00%

Volume

1.6M

Avg. volume

2.6M

P/E ratio

-7.25

Ocular Therapeutix, Inc. - Common Stock News